Pharma & Healthcare
Global Gastrointestinal Market Research Report 2025
- May 05, 25
- ID: 229261
- Pages: 87
- Figures: 89
- Views: 29
The global market for Gastrointestinal was valued at US$ 37060 million in the year 2024 and is projected to reach a revised size of US$ 46370 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn"s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal.
The Gastrointestinal market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn"s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal.
The Gastrointestinal market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Market Perspective (2020-2031)
2.2 Global Gastrointestinal Growth Trends by Region
2.2.1 Global Gastrointestinal Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastrointestinal Historic Market Size by Region (2020-2025)
2.2.3 Gastrointestinal Forecasted Market Size by Region (2026-2031)
2.3 Gastrointestinal Market Dynamics
2.3.1 Gastrointestinal Industry Trends
2.3.2 Gastrointestinal Market Drivers
2.3.3 Gastrointestinal Market Challenges
2.3.4 Gastrointestinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Players by Revenue
3.1.1 Global Top Gastrointestinal Players by Revenue (2020-2025)
3.1.2 Global Gastrointestinal Revenue Market Share by Players (2020-2025)
3.2 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastrointestinal Revenue
3.4 Global Gastrointestinal Market Concentration Ratio
3.4.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2024
3.5 Global Key Players of Gastrointestinal Head office and Area Served
3.6 Global Key Players of Gastrointestinal, Product and Application
3.7 Global Key Players of Gastrointestinal, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Breakdown Data by Type
4.1 Global Gastrointestinal Historic Market Size by Type (2020-2025)
4.2 Global Gastrointestinal Forecasted Market Size by Type (2026-2031)
5 Gastrointestinal Breakdown Data by Application
5.1 Global Gastrointestinal Historic Market Size by Application (2020-2025)
5.2 Global Gastrointestinal Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastrointestinal Market Size (2020-2031)
6.2 North America Gastrointestinal Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastrointestinal Market Size by Country (2020-2025)
6.4 North America Gastrointestinal Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Market Size (2020-2031)
7.2 Europe Gastrointestinal Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastrointestinal Market Size by Country (2020-2025)
7.4 Europe Gastrointestinal Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Market Size (2020-2031)
8.2 Asia-Pacific Gastrointestinal Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastrointestinal Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastrointestinal Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Market Size (2020-2031)
9.2 Latin America Gastrointestinal Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastrointestinal Market Size by Country (2020-2025)
9.4 Latin America Gastrointestinal Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Market Size (2020-2031)
10.2 Middle East & Africa Gastrointestinal Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastrointestinal Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastrointestinal Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZenec
11.1.1 AstraZenec Company Details
11.1.2 AstraZenec Business Overview
11.1.3 AstraZenec Gastrointestinal Introduction
11.1.4 AstraZenec Revenue in Gastrointestinal Business (2020-2025)
11.1.5 AstraZenec Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Gastrointestinal Introduction
11.2.4 Sanofi Revenue in Gastrointestinal Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Gastrointestinal Introduction
11.3.4 Bayer Revenue in Gastrointestinal Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gastrointestinal Introduction
11.4.4 Pfizer Revenue in Gastrointestinal Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Gastrointestinal Introduction
11.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2020-2025)
11.5.5 GlaxoSmithKline Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Gastrointestinal Introduction
11.6.4 Teva Revenue in Gastrointestinal Business (2020-2025)
11.6.5 Teva Recent Development
11.7 Zeria（Tillotts）
11.7.1 Zeria（Tillotts） Company Details
11.7.2 Zeria（Tillotts） Business Overview
11.7.3 Zeria（Tillotts） Gastrointestinal Introduction
11.7.4 Zeria（Tillotts） Revenue in Gastrointestinal Business (2020-2025)
11.7.5 Zeria（Tillotts） Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Details
11.8.2 Perrigo Business Overview
11.8.3 Perrigo Gastrointestinal Introduction
11.8.4 Perrigo Revenue in Gastrointestinal Business (2020-2025)
11.8.5 Perrigo Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Gastrointestinal Introduction
11.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2020-2025)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Details
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Gastrointestinal Introduction
11.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2020-2025)
11.10.5 Purdue Pharma Recent Development
11.11 C.B. Fleet
11.11.1 C.B. Fleet Company Details
11.11.2 C.B. Fleet Business Overview
11.11.3 C.B. Fleet Gastrointestinal Introduction
11.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2020-2025)
11.11.5 C.B. Fleet Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Gastrointestinal Introduction
11.12.4 Abbott Revenue in Gastrointestinal Business (2020-2025)
11.12.5 Abbott Recent Development
11.13 Jiangzhong
11.13.1 Jiangzhong Company Details
11.13.2 Jiangzhong Business Overview
11.13.3 Jiangzhong Gastrointestinal Introduction
11.13.4 Jiangzhong Revenue in Gastrointestinal Business (2020-2025)
11.13.5 Jiangzhong Recent Development
11.14 Xian-Janssen
11.14.1 Xian-Janssen Company Details
11.14.2 Xian-Janssen Business Overview
11.14.3 Xian-Janssen Gastrointestinal Introduction
11.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2020-2025)
11.14.5 Xian-Janssen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Market Perspective (2020-2031)
2.2 Global Gastrointestinal Growth Trends by Region
2.2.1 Global Gastrointestinal Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastrointestinal Historic Market Size by Region (2020-2025)
2.2.3 Gastrointestinal Forecasted Market Size by Region (2026-2031)
2.3 Gastrointestinal Market Dynamics
2.3.1 Gastrointestinal Industry Trends
2.3.2 Gastrointestinal Market Drivers
2.3.3 Gastrointestinal Market Challenges
2.3.4 Gastrointestinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Players by Revenue
3.1.1 Global Top Gastrointestinal Players by Revenue (2020-2025)
3.1.2 Global Gastrointestinal Revenue Market Share by Players (2020-2025)
3.2 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastrointestinal Revenue
3.4 Global Gastrointestinal Market Concentration Ratio
3.4.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2024
3.5 Global Key Players of Gastrointestinal Head office and Area Served
3.6 Global Key Players of Gastrointestinal, Product and Application
3.7 Global Key Players of Gastrointestinal, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Breakdown Data by Type
4.1 Global Gastrointestinal Historic Market Size by Type (2020-2025)
4.2 Global Gastrointestinal Forecasted Market Size by Type (2026-2031)
5 Gastrointestinal Breakdown Data by Application
5.1 Global Gastrointestinal Historic Market Size by Application (2020-2025)
5.2 Global Gastrointestinal Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastrointestinal Market Size (2020-2031)
6.2 North America Gastrointestinal Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastrointestinal Market Size by Country (2020-2025)
6.4 North America Gastrointestinal Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Market Size (2020-2031)
7.2 Europe Gastrointestinal Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastrointestinal Market Size by Country (2020-2025)
7.4 Europe Gastrointestinal Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Market Size (2020-2031)
8.2 Asia-Pacific Gastrointestinal Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastrointestinal Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastrointestinal Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Market Size (2020-2031)
9.2 Latin America Gastrointestinal Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastrointestinal Market Size by Country (2020-2025)
9.4 Latin America Gastrointestinal Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Market Size (2020-2031)
10.2 Middle East & Africa Gastrointestinal Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastrointestinal Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastrointestinal Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZenec
11.1.1 AstraZenec Company Details
11.1.2 AstraZenec Business Overview
11.1.3 AstraZenec Gastrointestinal Introduction
11.1.4 AstraZenec Revenue in Gastrointestinal Business (2020-2025)
11.1.5 AstraZenec Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Gastrointestinal Introduction
11.2.4 Sanofi Revenue in Gastrointestinal Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Gastrointestinal Introduction
11.3.4 Bayer Revenue in Gastrointestinal Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gastrointestinal Introduction
11.4.4 Pfizer Revenue in Gastrointestinal Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Gastrointestinal Introduction
11.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2020-2025)
11.5.5 GlaxoSmithKline Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Gastrointestinal Introduction
11.6.4 Teva Revenue in Gastrointestinal Business (2020-2025)
11.6.5 Teva Recent Development
11.7 Zeria（Tillotts）
11.7.1 Zeria（Tillotts） Company Details
11.7.2 Zeria（Tillotts） Business Overview
11.7.3 Zeria（Tillotts） Gastrointestinal Introduction
11.7.4 Zeria（Tillotts） Revenue in Gastrointestinal Business (2020-2025)
11.7.5 Zeria（Tillotts） Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Details
11.8.2 Perrigo Business Overview
11.8.3 Perrigo Gastrointestinal Introduction
11.8.4 Perrigo Revenue in Gastrointestinal Business (2020-2025)
11.8.5 Perrigo Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Gastrointestinal Introduction
11.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2020-2025)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Details
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Gastrointestinal Introduction
11.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2020-2025)
11.10.5 Purdue Pharma Recent Development
11.11 C.B. Fleet
11.11.1 C.B. Fleet Company Details
11.11.2 C.B. Fleet Business Overview
11.11.3 C.B. Fleet Gastrointestinal Introduction
11.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2020-2025)
11.11.5 C.B. Fleet Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Gastrointestinal Introduction
11.12.4 Abbott Revenue in Gastrointestinal Business (2020-2025)
11.12.5 Abbott Recent Development
11.13 Jiangzhong
11.13.1 Jiangzhong Company Details
11.13.2 Jiangzhong Business Overview
11.13.3 Jiangzhong Gastrointestinal Introduction
11.13.4 Jiangzhong Revenue in Gastrointestinal Business (2020-2025)
11.13.5 Jiangzhong Recent Development
11.14 Xian-Janssen
11.14.1 Xian-Janssen Company Details
11.14.2 Xian-Janssen Business Overview
11.14.3 Xian-Janssen Gastrointestinal Introduction
11.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2020-2025)
11.14.5 Xian-Janssen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prescription Gastrointestinal Drug
Table 3. Key Players of OTC Gastrointestinal Drug
Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gastrointestinal Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gastrointestinal Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gastrointestinal Market Share by Region (2020-2025)
Table 8. Global Gastrointestinal Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gastrointestinal Market Share by Region (2026-2031)
Table 10. Gastrointestinal Market Trends
Table 11. Gastrointestinal Market Drivers
Table 12. Gastrointestinal Market Challenges
Table 13. Gastrointestinal Market Restraints
Table 14. Global Gastrointestinal Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gastrointestinal Market Share by Players (2020-2025)
Table 16. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2024)
Table 17. Ranking of Global Top Gastrointestinal Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gastrointestinal, Headquarters and Area Served
Table 20. Global Key Players of Gastrointestinal, Product and Application
Table 21. Global Key Players of Gastrointestinal, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gastrointestinal Revenue Market Share by Type (2020-2025)
Table 25. Global Gastrointestinal Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gastrointestinal Revenue Market Share by Type (2026-2031)
Table 27. Global Gastrointestinal Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gastrointestinal Revenue Market Share by Application (2020-2025)
Table 29. Global Gastrointestinal Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gastrointestinal Revenue Market Share by Application (2026-2031)
Table 31. North America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gastrointestinal Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gastrointestinal Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gastrointestinal Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gastrointestinal Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gastrointestinal Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gastrointestinal Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gastrointestinal Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gastrointestinal Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gastrointestinal Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Market Size by Country (2026-2031) & (US$ Million)
Table 46. AstraZenec Company Details
Table 47. AstraZenec Business Overview
Table 48. AstraZenec Gastrointestinal Product
Table 49. AstraZenec Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 50. AstraZenec Recent Development
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi Gastrointestinal Product
Table 54. Sanofi Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Bayer Company Details
Table 57. Bayer Business Overview
Table 58. Bayer Gastrointestinal Product
Table 59. Bayer Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 60. Bayer Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Gastrointestinal Product
Table 64. Pfizer Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Gastrointestinal Product
Table 69. GlaxoSmithKline Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Gastrointestinal Product
Table 74. Teva Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Zeria（Tillotts） Company Details
Table 77. Zeria（Tillotts） Business Overview
Table 78. Zeria（Tillotts） Gastrointestinal Product
Table 79. Zeria（Tillotts） Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 80. Zeria（Tillotts） Recent Development
Table 81. Perrigo Company Details
Table 82. Perrigo Business Overview
Table 83. Perrigo Gastrointestinal Product
Table 84. Perrigo Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 85. Perrigo Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Gastrointestinal Product
Table 89. Boehringer Ingelheim Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Purdue Pharma Company Details
Table 92. Purdue Pharma Business Overview
Table 93. Purdue Pharma Gastrointestinal Product
Table 94. Purdue Pharma Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 95. Purdue Pharma Recent Development
Table 96. C.B. Fleet Company Details
Table 97. C.B. Fleet Business Overview
Table 98. C.B. Fleet Gastrointestinal Product
Table 99. C.B. Fleet Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 100. C.B. Fleet Recent Development
Table 101. Abbott Company Details
Table 102. Abbott Business Overview
Table 103. Abbott Gastrointestinal Product
Table 104. Abbott Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 105. Abbott Recent Development
Table 106. Jiangzhong Company Details
Table 107. Jiangzhong Business Overview
Table 108. Jiangzhong Gastrointestinal Product
Table 109. Jiangzhong Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 110. Jiangzhong Recent Development
Table 111. Xian-Janssen Company Details
Table 112. Xian-Janssen Business Overview
Table 113. Xian-Janssen Gastrointestinal Product
Table 114. Xian-Janssen Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 115. Xian-Janssen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Gastrointestinal Picture
Figure 2. Global Gastrointestinal Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gastrointestinal Market Share by Type: 2024 VS 2031
Figure 4. Prescription Gastrointestinal Drug Features
Figure 5. OTC Gastrointestinal Drug Features
Figure 6. Global Gastrointestinal Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gastrointestinal Market Share by Application: 2024 VS 2031
Figure 8. Chronic Gastritis Case Studies
Figure 9. Functional Dyspepsia Case Studies
Figure 10. Peptic Ulcer Case Studies
Figure 11. Acute Gastroenteritis Case Studies
Figure 12. Others Case Studies
Figure 13. Gastrointestinal Report Years Considered
Figure 14. Global Gastrointestinal Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Gastrointestinal Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Gastrointestinal Market Share by Region: 2024 VS 2031
Figure 17. Global Gastrointestinal Market Share by Players in 2024
Figure 18. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2024
Figure 20. North America Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Gastrointestinal Market Share by Country (2020-2031)
Figure 22. United States Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Gastrointestinal Market Share by Country (2020-2031)
Figure 26. Germany Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Gastrointestinal Market Share by Region (2020-2031)
Figure 34. China Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Gastrointestinal Market Share by Country (2020-2031)
Figure 42. Mexico Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Gastrointestinal Market Share by Country (2020-2031)
Figure 46. Turkey Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 54. Teva Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 55. Zeria（Tillotts） Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 56. Perrigo Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 58. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 59. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 60. Abbott Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 61. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 62. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prescription Gastrointestinal Drug
Table 3. Key Players of OTC Gastrointestinal Drug
Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gastrointestinal Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gastrointestinal Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gastrointestinal Market Share by Region (2020-2025)
Table 8. Global Gastrointestinal Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gastrointestinal Market Share by Region (2026-2031)
Table 10. Gastrointestinal Market Trends
Table 11. Gastrointestinal Market Drivers
Table 12. Gastrointestinal Market Challenges
Table 13. Gastrointestinal Market Restraints
Table 14. Global Gastrointestinal Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gastrointestinal Market Share by Players (2020-2025)
Table 16. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2024)
Table 17. Ranking of Global Top Gastrointestinal Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gastrointestinal, Headquarters and Area Served
Table 20. Global Key Players of Gastrointestinal, Product and Application
Table 21. Global Key Players of Gastrointestinal, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gastrointestinal Revenue Market Share by Type (2020-2025)
Table 25. Global Gastrointestinal Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gastrointestinal Revenue Market Share by Type (2026-2031)
Table 27. Global Gastrointestinal Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gastrointestinal Revenue Market Share by Application (2020-2025)
Table 29. Global Gastrointestinal Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gastrointestinal Revenue Market Share by Application (2026-2031)
Table 31. North America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gastrointestinal Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gastrointestinal Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gastrointestinal Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gastrointestinal Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gastrointestinal Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gastrointestinal Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gastrointestinal Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gastrointestinal Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gastrointestinal Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Market Size by Country (2026-2031) & (US$ Million)
Table 46. AstraZenec Company Details
Table 47. AstraZenec Business Overview
Table 48. AstraZenec Gastrointestinal Product
Table 49. AstraZenec Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 50. AstraZenec Recent Development
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi Gastrointestinal Product
Table 54. Sanofi Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Bayer Company Details
Table 57. Bayer Business Overview
Table 58. Bayer Gastrointestinal Product
Table 59. Bayer Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 60. Bayer Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Gastrointestinal Product
Table 64. Pfizer Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Gastrointestinal Product
Table 69. GlaxoSmithKline Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Gastrointestinal Product
Table 74. Teva Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Zeria（Tillotts） Company Details
Table 77. Zeria（Tillotts） Business Overview
Table 78. Zeria（Tillotts） Gastrointestinal Product
Table 79. Zeria（Tillotts） Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 80. Zeria（Tillotts） Recent Development
Table 81. Perrigo Company Details
Table 82. Perrigo Business Overview
Table 83. Perrigo Gastrointestinal Product
Table 84. Perrigo Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 85. Perrigo Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Gastrointestinal Product
Table 89. Boehringer Ingelheim Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Purdue Pharma Company Details
Table 92. Purdue Pharma Business Overview
Table 93. Purdue Pharma Gastrointestinal Product
Table 94. Purdue Pharma Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 95. Purdue Pharma Recent Development
Table 96. C.B. Fleet Company Details
Table 97. C.B. Fleet Business Overview
Table 98. C.B. Fleet Gastrointestinal Product
Table 99. C.B. Fleet Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 100. C.B. Fleet Recent Development
Table 101. Abbott Company Details
Table 102. Abbott Business Overview
Table 103. Abbott Gastrointestinal Product
Table 104. Abbott Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 105. Abbott Recent Development
Table 106. Jiangzhong Company Details
Table 107. Jiangzhong Business Overview
Table 108. Jiangzhong Gastrointestinal Product
Table 109. Jiangzhong Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 110. Jiangzhong Recent Development
Table 111. Xian-Janssen Company Details
Table 112. Xian-Janssen Business Overview
Table 113. Xian-Janssen Gastrointestinal Product
Table 114. Xian-Janssen Revenue in Gastrointestinal Business (2020-2025) & (US$ Million)
Table 115. Xian-Janssen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Gastrointestinal Picture
Figure 2. Global Gastrointestinal Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gastrointestinal Market Share by Type: 2024 VS 2031
Figure 4. Prescription Gastrointestinal Drug Features
Figure 5. OTC Gastrointestinal Drug Features
Figure 6. Global Gastrointestinal Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gastrointestinal Market Share by Application: 2024 VS 2031
Figure 8. Chronic Gastritis Case Studies
Figure 9. Functional Dyspepsia Case Studies
Figure 10. Peptic Ulcer Case Studies
Figure 11. Acute Gastroenteritis Case Studies
Figure 12. Others Case Studies
Figure 13. Gastrointestinal Report Years Considered
Figure 14. Global Gastrointestinal Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Gastrointestinal Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Gastrointestinal Market Share by Region: 2024 VS 2031
Figure 17. Global Gastrointestinal Market Share by Players in 2024
Figure 18. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2024
Figure 20. North America Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Gastrointestinal Market Share by Country (2020-2031)
Figure 22. United States Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Gastrointestinal Market Share by Country (2020-2031)
Figure 26. Germany Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Gastrointestinal Market Share by Region (2020-2031)
Figure 34. China Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Gastrointestinal Market Share by Country (2020-2031)
Figure 42. Mexico Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Gastrointestinal Market Share by Country (2020-2031)
Figure 46. Turkey Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Gastrointestinal Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 54. Teva Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 55. Zeria（Tillotts） Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 56. Perrigo Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 58. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 59. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 60. Abbott Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 61. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 62. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232